Watch Ticker

Werewolf Therapeutics, Inc. Common Stock

Go to Werewolf Therapeutics, Inc. Common Stock Website

$1.19

-0.02 (-1.65%)

Live

Previous Close

$1.19

Day Range

$1.19 - $1.24

Previous Day Range

$1.21 - $1.29

Market Cap

$54.3 million USD

Day Vol.

103932

Previous Day Vol.

66020

Currency

USD

Primary Exchange

Nasdaq

Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditional...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Werewolf Therapeutics, Inc. - Werewolf Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Update

Werewolf Therapeutics provided updates on its clinical trials, including progress with WTX-124 and WTX-330, and announced the development of its proprietary INDUCER T cell engager molecules. The company also reported its financial results for the first quarter of 2025, with a cash runway into the fourth quarter of 2026.

Related tickers: HOWL.

Read Full Article

Globe Newswire - Werewolf Therapeutics Appoints Steven Bloom as Chief Business Officer

Werewolf Therapeutics, a biopharmaceutical company, announced the appointment of Steven Bloom as Chief Business Officer. Bloom brings over 35 years of experience in the life sciences industry and will help Werewolf navigate important milestones, including data from a clinical trial and pipeline development.

Related tickers: HOWL.

Read Full Article

Trending Tickers

Please sign in to view